Skip to content

Evaluation of an electronic Oral Glucose Tolerance Test Kit (eOGTTK)

Evaluation of an electronic Oral Glucose Tolerance Test Kit: a randomized crossover study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN91288133
Enrollment
30
Registered
2012-04-27
Start date
2011-04-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes (type 2) Nutritional, Metabolic, Endocrine Non-insulin-dependent diabetes mellitus

Interventions

Participants used the eOGTTK on six occasions in three settings: 1. Two home based (and unobserved) tests 2. Two clinic based and observed tests (preferably without any nurse intervention) 3. Two clin

Sponsors

Novartis Pharma AG (Switzerland)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Willing and able to give informed consent for participation in the study 2. Aged 18 years or above 3. Had adequate vision and reading comprehension to follow the electronic OGTT kit instructions in English 4. Patients with type 2 diabetes were: 4.1. Treated with diet alone or with metformin monotherapy 4.2. Had stable therapy for at least 3 months prior to study enrollment or 5. Individuals without diagnosed diabetes had no prior experience of an OGTT or any tests which involved finger-pricking

Exclusion criteria

Exclusion criteria: 1. Pregnancy or planned pregnancy during the study period 2. Participant taking drugs that may affect glucose levels 3. History or current evidence of any condition, therapy, laboratory abnormality, or other circumstance which, in the opinion of the investigator, posed an unacceptable risk to the individual, confounded the results of the study, or was likely to interfere with the individual?s participation of the full duration of the trial

Design outcomes

Primary

MeasureTime frame
To evaluate the precision of the eOGTTK by assessing: 1. Repeatability: the degree of variation when assessed in different settings 2. Reproducibility: the degree of variation within each setting

Secondary

MeasureTime frame
1. To evaluate the user acceptability of the eOGTTK through the use of a validated device satisfaction questionnaire and focus groups 2. To investigate any possible training effects with repeated eOGTTK use 3. To evaluate the accuracy of the eOGTTK 0? and 120? values compared with laboratory measured venous plasma glucose values

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026